Pyxis Oncology, Inc. financial data

Symbol
PYXS on Nasdaq
Location
321 Harrison Avenue, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 703 % +0.28%
Debt-to-equity 31.5 % +13.4%
Return On Equity -82.8 % -116%
Return On Assets -63 % -110%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62M shares +5.22%
Common Stock, Shares, Outstanding 62M shares +5.27%
Common Stock, Value, Issued 62K USD +5.09%
Weighted Average Number of Shares Outstanding, Basic 61.9M shares +2.35%
Weighted Average Number of Shares Outstanding, Diluted 61.9M shares +2.35%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.82M USD
Research and Development Expense 65.9M USD +23.8%
General and Administrative Expense 22.4M USD -28.1%
Operating Income (Loss) -106M USD -54.9%
Nonoperating Income (Expense) 8.32M USD -12.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.1M USD -4.45%
Income Tax Expense (Benefit) 283K USD
Net Income (Loss) Attributable to Parent -96.3M USD -62.6%
Earnings Per Share, Basic -1 USD/shares -29.6%
Earnings Per Share, Diluted -1 USD/shares -29.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.7M USD -57.2%
Marketable Securities, Current 78.2M USD -40.1%
Cash, Cash Equivalents, and Short-term Investments 88.9M USD -42.9%
Accounts Receivable, after Allowance for Credit Loss, Current 3M USD
Assets, Current 100M USD -37.9%
Property, Plant and Equipment, Net 8.92M USD -19.4%
Operating Lease, Right-of-Use Asset 11.8M USD
Intangible Assets, Net (Excluding Goodwill) 2.49M USD -89.5%
Assets 123M USD -40.9%
Accounts Payable, Current 9.41M USD +72.1%
Accrued Liabilities, Current 6.7M USD -33.6%
Liabilities, Current 17.7M USD +4.62%
Operating Lease, Liability, Noncurrent 17.8M USD -8.08%
Liabilities 35.6M USD -7.83%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5K USD +95.1%
Retained Earnings (Accumulated Deficit) -403M USD -31.4%
Stockholders' Equity Attributable to Parent 87.6M USD -48.4%
Liabilities and Equity 123M USD -40.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.5M USD -8.81%
Net Cash Provided by (Used in) Investing Activities 15.8M USD
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 62M shares +5.27%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.71M USD -137%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.2M USD -54%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -96.2M USD -62.4%
Operating Lease, Liability, Current 1.57M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 800K USD 0%
Additional Paid in Capital 491M USD +2.95%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 552K USD -50.5%
Share-based Payment Arrangement, Expense 12.4M USD -20.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%